These Analysts Revise Their Forecasts On Thermo Fisher Scientific Following Upbeat Earnings - Thermo Fisher Scientific (NYSE:TMO)
Stay updated with breaking news from Diagnostics Segment. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Discover Thermo Fisher Scientific Inc's (NYSE: TMO) Q1 earnings: $10.34 billion revenue, down 3% Y/Y, with beats in EPS and guidance. Dive into details now.
Unveiling the Strengths and Challenges: A Deep Dive into Hologic Inc (HOLX) SWOT Analysis
"Thermo Fisher Scientific surpasses Q4 revenue expectations at $10.89B, down 5% YoY. Analytical Instruments Segment rises 8.5%. Financial highlights and 2024 revenue guidance.
/PRNewswire/ -- The "Global Point of Care Testing Market (By Diagnostics Segment, Mode, End Users, Regions), 100 Company Profiles" report has been added to...